Basically involved in health solutions by providing e-business solutions to a lot of the insurance and pharmacy companies and is showing decent growth. Very strong cash position. Earnings are looking at about $.31 for the year. Have been buying back stock and making some small tuck in acquisitions.
Basically involved in health solutions by providing e-business solutions to a lot of the insurance and pharmacy companies and is showing decent growth. Very strong cash position. Earnings are looking at about $.31 for the year. Have been buying back stock and making some small tuck in acquisitions.
Provides back-office solution for some financial companies and health related companies. Just reported and numbers were good. Made a couple of acquisitions. Strong cash position. Earnings outlook is $.31 this year and should grow to $.43.
Provides back-office solution for some financial companies and health related companies. Just reported and numbers were good. Made a couple of acquisitions. Strong cash position. Earnings outlook is $.31 this year and should grow to $.43.
(A Top Pick July 25/06. Up 35%.) Recently added to his position. Has gone through a revolving door of management teams. New management is stable. Cheap.
(A Top Pick July 25/06. Up 35%.) Recently added to his position. Has gone through a revolving door of management teams. New management is stable. Cheap.
Back-office settlement of pharmacy companies and health care operations. Have a major contracts with insurers. Likes the recurring revenue theme. Doing a good job of building new orders. Strong balance sheet.
Back-office settlement of pharmacy companies and health care operations. Have a major contracts with insurers. Likes the recurring revenue theme. Doing a good job of building new orders. Strong balance sheet.
Recurring revenue model. Focusing on the high-growth area. Earnings outlook continues to look good. Very strong balance sheet and close to $100 million in cash.
Recurring revenue model. Focusing on the high-growth area. Earnings outlook continues to look good. Very strong balance sheet and close to $100 million in cash.
A fair amount of their business is geared towards the health side of life. One at $25 million contract with Newfoundland and are bidding on a couple of others. Quebec contract may be awarded in September. If they get this one, it could boost their earnings by 8/12% for 2007.
A fair amount of their business is geared towards the health side of life. One at $25 million contract with Newfoundland and are bidding on a couple of others. Quebec contract may be awarded in September. If they get this one, it could boost their earnings by 8/12% for 2007.
Has a backlog and is gearing up to the health side. Analysts are expecting earnings of $.04 this Friday. Earnings for 06 are expected to increase from $.16 to $.25 in 07.
Has a backlog and is gearing up to the health side. Analysts are expecting earnings of $.04 this Friday. Earnings for 06 are expected to increase from $.16 to $.25 in 07.
Has unfortunately had a revolving door of management over the last 4 years. Ranked 547 out of 700 stocks in his database model. Earnings are suffering, but are expected to improve from a loss of $0.21 to a loss of $0.02 in '05. Sales have gone down by 33% year over year. Earnings are forcast to be $0.01 in '06. Against a stock of $3, it puts a PE multiple in excess of 200 X.
Has unfortunately had a revolving door of management over the last 4 years. Ranked 547 out of 700 stocks in his database model. Earnings are suffering, but are expected to improve from a loss of $0.21 to a loss of $0.02 in '05. Sales have gone down by 33% year over year. Earnings are forcast to be $0.01 in '06. Against a stock of $3, it puts a PE multiple in excess of 200 X.